PMA supplement

P010031 S933: Cobalt MRI CRT-D (DTPB2Dl, DTPB2D4, DTPB2Ql, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2Dl, DTPA2D4, DTPA2Ql, DTPA2QQ); Crome M

FDA PMA supplement · 30-Day Notice · Medtronic Cardiac Rhythm Disease Management

Key facts

Original PMA P010031
Supplement number S933
Supplement type 30-Day Notice
Reason for the supplement Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name Cobalt MRI CRT-D (DTPB2Dl, DTPB2D4, DTPB2Ql, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2Dl, DTPA2D4, DTPA2Ql, DTPA2QQ); Crome M
Generic name Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
Applicant Medtronic Cardiac Rhythm Disease Management
Product code NIK
Received date Sep 11, 2026
Decision date Oct 5, 2026

At a glance

  • No Expedited review granted
  • No Approval order on file
  • No Summary of safety and effectiveness on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA supplements

A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA supplements